FDA won’t allow Invivyd’s Pemgarda to treat Covid; Antibiotic biotech launches

Plus, news about BioCryst, AN2 Therapeutics, OS Therapies and Eyenovia: FDA is not expanding Invivyd’s Covid-19 EUA: The regulators declined to allow Pemgarda’s existing EUA to include treatment of mild-to-moderate Covid ...